76
Views
2
CrossRef citations to date
0
Altmetric
Review

The Freedom SOLO bovine pericardial stentless valve

, &
Pages 349-361 | Published online: 02 Dec 2014

References

  • Hufnagel CA, Harvey WP, Rabil PJ, McDermott TF. Surgical correction of aortic insufficiency. Surgery. 1954;35(5):673–683.
  • Ross DN. Homograft replacement of the aortic valve. Lancet. 1962; 2(7254):487–488.
  • Barratt-Boyes BG. Homograft aortic valve replacement in aortic incompetence and stenosis. Thorax. 1964;19(2):131–150.
  • Harken DE, Soroff HS, Taylor WJ, Lefemine AA, Gupta SK, Lunzer S. Partial and complete prostheses in aortic insufficiency. J Thorac Cardiovasc Surg. 1960;40:744–762.
  • Weldon CS, Ameli MM, Morovati SS, Shaker IJ. A prosthetic stented aortic homograft for mitral valve replacement. J Surg Res. 1966;6(12):548–552.
  • Duran CG, Gunning AJ. Heterologous aortic valve transplantation in the dog. Lancet. 1965;1(7403):114–115.
  • Binet JP, Carpentier A, Langlois J, Duran C, Colvez P. [Implantation of heterogenic valves in the treatment of aortic cardiopathies]. C R Acad Sci Hebd Seances Acad Sci D. 1965;261(25):5733–5734. French.
  • Binet JP, Duran CG, Carpentier A, Langlois J. Heterologous aortic valve transplantation. Lancet. 1965;286(7425):1275.
  • Carpentier A, Deloche A, Relland J, et al. Six-year follow-up of glutaraldehyde-preserved heterografts. With particular reference to the treatment of congenital valve malformations. J Thorac Cardiovasc Surg. 1974;68(5):771–782.
  • Reis RL, Hancock WD, Yarbrough JW, Glancy DL, Morrow AG. The flexible stent. A new concept in the fabrication of tissue heart valve prostheses. J Thorac Cardiovasc Surg. 1971;62(5):683–689.
  • Bortolotti U, Milano A, Thiene G, et al. Early mechanical failures of the Hancock pericardial xenograft. J Thorac Cardiovasc Surg. 1987;94(2):200–207.
  • Harken DE. Heart valves: ten commandments and still counting. Ann Thorac Surg. 1989;48(Suppl 3):S18–S19.
  • Walkes JC, Reardon MJ. Current thinking in stentless valve surgery. Curr Opin Cardiol. 2003;18(2):117–123.
  • O’Brien MF. The Cryolife-O’Brien composite aortic stentless xenograft: surgical technique of implantation. Ann Thorac Surg. 1995; 60(Suppl 2):S410–S413.
  • Dagum P, Green GR, Nistal FJ, et al. Deformational dynamics of the aortic root: modes and physiologic determinants. Circulation. 1999;100(Suppl 19):II54–II62.
  • Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322(22):1561–1566.
  • Lund O. Valve replacement for aortic stenosis: the curative potential of early operation. Scand J Thorac Cardiovasc Surg Suppl. 1993;40:S1–S137.
  • Stacchino C, Bona G, Rinaldi S, Vallana F. Design and performance characteristics of the Pericarbon Stentless valve. J Heart Valve Dis. 1995;4 Suppl 1:S102–S105.
  • Stacchino C, Bona G, Bonetti F, et al A. Grignani. Detoxification process for glutaraldehyde-treated bovine pericardium: biological, chemical and mechanical characterization. J Heart Valve Dis. 1998;7(2),190–194.
  • Repossini A, Kotelnikov I, Bouchikhi R, et al. Single-suture line placement of a pericardial stentless valve. J Thorac Cardiovasc Surg. 2005;130(5):1265–1269.
  • O’Brien MF. Implantation technique of the Cryolife-O’Brien stentless xenograft aortic valve: the simple, rapid, and correct way to implant and the errors to avoid. Semin Thorac Cardiovasc Surg. 1999;11(4 Suppl 1):S121–S125.
  • Scharfschwerdt M, Sievers HH, Hussein A, Kraatz EG, Misfeld M. Impact of progressive sinotubular junction dilatation on valve competence of the 3F Aortic and Sorin Solo stentless bioprosthetic heart valves. Eur J Cardiothorac Surg. 2010;37(3):631–634.
  • David TE, Feindel CM, Bos J, Ivanov J, Armstrong S. Aortic valve replacement with Toronto SPV bioprosthesis: optimal patient survival but suboptimal valve durability. J Thorac Cardiovasc Surg. 2008;135(1):19–24.
  • Glauber M, Solinas M, Karimov J. Technique for implant of the stentless aortic valve Freedom Solo. Multimed Man Cardiothorac Surg [serial on the Internet]. Jan 2007 [cited September 21, 2014]; 2007(1018):[about 10 p]. http://mmcts.oxfordjournals.org/content/2007/1018/mmcts.2007.002618.full.pdf+html. Accessed September 21, 2014.
  • Permanyer E, Ginel A, Muñoz-Guijosa C, Padró JM. The Sorin Freedom SOLO stentless aortic valve: easier implantation technique with potentially less risk of complications. Eur J Cardiothorac Surg. 2011;40(5):1263–1264.
  • Beholz S, Konertz WE. Avoiding early partial valve thrombosis of the Pericarbon Freedom stentless valve. J Heart Valve Dis. 2007; 16(1):91–92.
  • Hilker L, Wodny M, Ginesta M, Wollert HG, Eckel L. Differences in the recovery of platelet counts after biological aortic valve replacement. Interact Cardiovasc Thorac Surg. 2009;8(1):70–73.
  • Sinha P, Zurakowski D, Kumar TK, He D, Rossi C, Jonas RA. Effects of glutaraldehyde concentration, pretreatment time, and type of tissue (porcine versus bovine) on postimplantation calcification. J Thorac Cardiovasc Surg. 2012;143(1):224–227.
  • Valente M, Pettenazzo E, Thiene G, et al. Detoxified glutaraldehyde cross-linked pericardium: tissue preservation and mineralization mitigation in a subcutaneous rat model. J Heart Valve Dis. 1998;7(3):283–291.
  • Ozaki S, Herijgers P, Flameng W. Influence of blood contact on the calcification of glutaraldehyde-pretreated porcine aortic valves. Ann Thorac Cardiovasc Surg. 2003;9(4):245–252.
  • Perrotta S, Lentini S. In patients with severe active aortic valve endocarditis, is a stentless valve as good as the homograft? Interact Cardiovasc Thorac Surg. 2010;11(3):309–313.
  • Oses P, Guibaud JP, Elia N, et al. Freedom SOLO valve: early- and intermediate-term results of a single centre’s first 100 cases. Eur J Cardiothorac Surg. 2011;39(2):256–261.
  • Iliopoulos DC, Deveja AR, Androutsopoulou V, et al. Single-center experience using the Freedom SOLO aortic bioprosthesis. J Thorac Cardiovasc Surg. 2013;146(1):96–102.
  • Beholz S, Repossini A, Livi U, et al. The Freedom SOLO valve for aortic valve replacement: clinical and hemodynamic results from a prospective multicenter trial. J Heart Valve Dis. 2010;19(1):115–123.
  • Horst M, Easo J, Hölzl PP, et al. The Freedom SOLO valve: mid-term clinical results with a stentless pericardial valve for aortic valve replacement. J Heart Valve Dis. 2011;20(6):704–710.
  • Repossini A, Rambaldini M, Lucchetti V, et al. Early clinical and haemodynamic results after aortic valve replacement with the Freedom SOLO bioprosthesis (experience of Italian multicenter study). Eur J Cardiothorac Surg. 2012;41(5):1104–1110.
  • Thalmann M, Kaiblinger J, Krausler R, et al. Clinical experience with the Freedom SOLO stentless aortic valve in 277 consecutive patients. Ann Thorac Surg. Epub August 20, 2014.
  • Aymard T, Eckstein F, Englberger L, Stalder M, Kadner A, Carrel T. The Sorin Freedom SOLO stentless aortic valve: technique of implantation and operative results in 109 patients. J Thorac Cardiovasc Surg. 2010;139(3):775–777.
  • Matthews IG, Fazal IA, Bates MG, Turley AJ. In patients undergoing aortic valve replacement, what factors predict the requirement for permanent pacemaker implantation? Interact Cardiovasc Thorac Surg. 2011;12(3):475–479.
  • Dellgren G, Feindel CM, Bos J, Ivanov J, David TE. Aortic valve replacement with the Toronto SPV: long-term clinical and hemodynamic results. Eur J Cardiothorac Surg. 2002;21(4):698–702.
  • Kunadian B, Vijayalakshmi K, Thornley AR, et al. Meta-analysis of valve hemodynamics and left ventricular mass regression for stentless versus stented aortic valves. Ann Thorac Surg. 2007;84(1):73–78.
  • Silberman S, Shaheen J, Fink D, et al. Comparison of exercise hemodynamics among nonstented aortic bioprostheses, mechanical valves, and normal native aortic valves. J Card Surg. 1998;13(5):412–416.
  • Del Rizzo DF, Abdoh A, Cartier P, Doty D, Westaby S. Factors affecting left ventricular mass regression after aortic valve replacement with stentless valves. Semin Thorac Cardiovasc Surg. 1999; 11(4 Suppl 1):114–120.
  • Maselli D, Pizio R, Bruno LP, Di Bella I, De Gasperis C. Left ventricular mass reduction after aortic valve replacement: homografts, stentless and stented valves. Ann Thorac Surg. 1999;67(4):966–971.
  • Walther T, Falk V, Langebartels G, et al. Regression of left ventricular hypertrophy after stentless versus conventional aortic valve replacement. Semin Thorac Cardiovasc Surg. 1999;11(4 Suppl 1):S18–S21.
  • Cohen G, Zagorski B, Christakis GT, et al. Are stentless valves hemodynamically superior to stented valves? Long-term follow-up of a randomized trial comparing Carpentier-Edwards pericardial valve with the Toronto Stentless Porcine Valve. J Thorac Cardiovasc Surg. 2010;139(4):848–859.
  • Funder JA. Current status on stentless aortic bioprosthesis: a clinical and experimental perspective. Eur J Cardiothorac Surg. 2012;41(4):790–799.
  • Pibarot P, Dumesnil JG. Prosthesis-patient mismatch: definition, clinical impact, and prevention. Heart. 2006;92(8):1022–1029.
  • Head SJ, Mokhles MM, Osnabrugge RL, et al. The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J. 2012;33(12):1518–1529.
  • Ugur M, Suri RM, Daly RC, et al. Comparison of early hemodynamic performance of 3 aortic valve bioprostheses. J Thorac Cardiovasc Surg. Epub January 15, 2014.
  • Bavaria JE, Desai ND, Cheung A, et al. The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study. J Thorac Cardiovasc Surg. 2014;147(2):590–597.
  • Wyss TR, Bigler M, Stalder M, et al. Absence of prosthesis-patient mismatch with the new generation of Edwards stented aortic bioprosthesis. Interact Cardiovasc Thorac Surg. 2010;10(6):884–887; discussion 887–888.
  • Wendt D, Thielmann M, Plicht B, et al. The new St Jude Trifecta versus Carpentier-Edwards Perimount Magna and Magna Ease aortic bioprosthesis: is there a hemodynamic superiority? J Thorac Cardiovasc Surg. 2014;147(5):1553–1560.
  • Bakhtiary F, Schiemann M, Dzemali O, et al. Stentless bioprostheses improve postoperative coronary flow more than stented prostheses after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg. 2006;131(4):883–888.
  • Britten MB, Zeiher AM, Schächinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis. 2004;15(5):259–264.
  • Hildick-Smith DJ, Shapiro LM. Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study. J Am Coll Cardiol. 2000;36(6):1889–1896.
  • Bakhtiary F, Schiemann M, Dzemali O, et al. Impact of patient-prosthesis mismatch and aortic valve design on coronary flow reserve after aortic valve replacement. J Am Coll Cardiol. 2007;49(7):790–796.
  • Pozzoli A, De Maat GE, Hillege HL, Boogaard JJ, Natour E, Mariani MA. Severe thrombocytopenia and its clinical impact after implant of the stentless Freedom Solo bioprosthesis. Ann Thorac Surg. 2013;96(5):1581–1586.
  • Yerebakan C, Kaminski A, Westphal B, et al. Thrombocytopenia after aortic valve replacement with the Freedom Solo stentless bioprosthesis. Interact Cardiovasc Thorac Surg. 2008;7(4):616–620.
  • Ravenni G, Celiento M, Ferrari G, et al. Reduction in platelet count after aortic valve replacement: comparison of three bioprostheses. J Heart Valve Dis. 2012;21(5):655–661.
  • Selleng S, Malowsky B, Strobel U, et al. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost. 2010;8(1):30–36.
  • Tarzia V, Bottio T, Buratto E, Spiezia L, Simioni P, Gerosa G. Freedom solo stentless aortic valve: quantitative and qualitative assessment of thrombocytopenia. Ann Thorac Surg. 2011;92(5):1935.
  • Khoo JP, Davies JE, Ang KL, Galiñanes M, Chin DT. Differences in performance of five types of aortic valve prostheses: haemodynamic assessment by dobutamine stress echocardiography. Heart. 2013;99(1):41–47.
  • Adalbert R, Engelhardt JI, Siklós L. DL-Homocysteic acid application disrupts calcium homeostasis and induces degeneration of spinal motor neurons in vivo. Acta Neuropathol. 2002;103(5):428–436.
  • Boldyrev AA. Molecular mechanisms of homocysteine toxicity. Biochemistry (Mosc). 2009;74(6):589–598.
  • Kobayashi J. Stentless aortic valve replacement: an update. Vasc Health Risk Manag. 2011;7:345–351.
  • Borger MA, Prasongsukarn K, Armstrong S, Feindel CM, David TE. Stentless aortic valve reoperations: a surgical challenge. Ann Thorac Surg. 2007;84(3):737–743; discussion 743–744.
  • Dvir D, Webb JG, Bleiziffer S, et al; Valve-in-Valve International Data Registry Investigators. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014;312(2):162–170.
  • Mecozzi G, Milano AD, De Carlo M, et al. Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study. J Thorac Cardiovasc Surg. 2002;123(3):550–556.
  • Desai ND, Merin O, Cohen GN, et al. Long-term results of aortic valve replacement with the St Jude Toronto stentless porcine valve. Ann Thorac Surg. 2004;78(6):2076–2083.
  • Pavoni D, Badano LP, Ius F, et al. Limited long-term durability of the Cryolife O’Brien stentless porcine xenograft valve. Circulation. 2007;116(Suppl 11):I307–I313.
  • Carrel TP, Schoenhoff FS, Schmidli J, Stalder M, Eckstein FS, Englberger L. Deleterious outcome of No-React-treated stentless valved conduits after aortic root replacement: why were warnings ignored? J Thorac Cardiovasc Surg. 2008;136(1):52–57.
  • Dellgren G, Eriksson MJ, Brodin LA, Rådegran K. Eleven years’ experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with long-term relative survival rate. Eur J Cardiothorac Surg. 2002;22(6):912–921.
  • Grande KJ, Cochran RP, Reinhall PG, Kunzelman KS. Mechanisms of aortic valve incompetence: finite element modeling of aortic root dilatation. Ann Thorac Surg. 2000;69(6):1851–1857.
  • Sripathi VC, Kumar RK, Balakrishnan KR. Further insights into normal aortic valve function: role of a compliant aortic root on leaflet opening and valve orifice area. Ann Thorac Surg. 2004;77(3):844–851.